Joanna Lipner is the Co-founder of Pikralida, a clinical-stage biopharmaceutical company developing innovative therapies through drug rediscovery. She focuses on building an organisation that transforms scientific concepts into viable business, with particular emphasis on governance, financing, and partnerships.
With over a decade of experience in pharmaceutical R&D and drug development, she has led companies through fundraising, international collaborations, and clinical trial readiness. At Pikralida, she has secured capital in a challenging market environment, prepared the organisation for multiple Phase II clinical trials, and initiated the development of a veterinary product in cooperation with external partners.
Joanna combines a PhD-level scientific background with a strong business perspective and leverages this experience to contribute to the wider conversation on deeptech innovation.
